•
Dec 31, 2024

Thermo Fisher Q4 2024 Earnings Report

Thermo Fisher Scientific reported strong revenue and earnings growth in Q4 2024.

Key Takeaways

Thermo Fisher Scientific reported a 5% increase in revenue to $11.40 billion for the fourth quarter of 2024. GAAP diluted EPS grew by 14% to $4.78, and adjusted EPS grew by 8% to $6.10. The company highlighted its focus on strengthening industry leadership and executing its capital deployment strategy.

Fourth quarter revenue grew 5% to $11.40 billion.

Fourth quarter GAAP diluted earnings per share (EPS) grew 14% to $4.78.

Fourth quarter adjusted EPS grew 8% to $6.10.

The company launched innovative new products and strengthened its commercial engine.

Total Revenue
$11.4B
Previous year: $10.9B
+4.7%
EPS
$6.1
Previous year: $5.67
+7.6%
Organic Revenue Growth
4%
Previous year: -7%
-157.1%
Adjusted Operating Margin
23.9%
Previous year: 23.4%
+2.1%
Gross Profit
$4.9B
Previous year: $4.5B
+9.1%
Cash and Equivalents
$4.01B
Previous year: $8.08B
-50.4%
Free Cash Flow
$2.83B
Previous year: $3.33B
-15.1%
Total Assets
$97.3B
Previous year: $98.7B
-1.4%

Thermo Fisher

Thermo Fisher

Thermo Fisher Revenue by Segment

Forward Guidance

The company will provide 2025 financial guidance during its earnings conference call this morning at 8:30 a.m. Eastern Time.

Revenue & Expenses

Visualization of income flow from segment revenue to net income